Free Trial

AVITA Medical Q3 2023 Earnings Report

AVITA Medical logo
$13.32 +0.32 (+2.46%)
(As of 12/3/2024 ET)

AVITA Medical EPS Results

Actual EPS
-$0.34
Consensus EPS
-$0.53
Beat/Miss
Beat by +$0.19
One Year Ago EPS
N/A

AVITA Medical Revenue Results

Actual Revenue
$13.65 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

AVITA Medical Announcement Details

Quarter
Q3 2023
Time
N/A
Elon Musk’s chilling warning for humanity (Ad)

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.

Go here to see why.

AVITA Medical Earnings Headlines

AVITA Medical, Inc. (RCEL): A Bull Case Theory
Expert: The most important message you’ll see in 2024
The message I'm sharing today could be the most important message of 2024. In short, America is being invaded… The invasion spreading across America is coming from the ports, highways, and railroads.
See More AVITA Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AVITA Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AVITA Medical and other key companies, straight to your email.

About AVITA Medical

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

View AVITA Medical Profile

More Earnings Resources from MarketBeat